Community case of methicillin-resistant Staphylococcus aureus infection [4]

Emerging Infectious Diseases

Volumn 12, Issue 1, 2006, Pages 172-174

  Nelson, Lee ^a   Cockram, Clive S ^a   Lui, Grace ^a   Lam, Rebecca ^a   Lam, Edman ^a   Lai, Raymond ^a   Ip, Margaret ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; CEFAZOLIN; CHLORAMPHENICOL; CIPROFLOXACIN; CLINDAMYCIN; CLOXACILLIN; COTRIMOXAZOLE; ERYTHROMYCIN; FUSIDIC ACID; GENTAMICIN; LINEZOLID; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; SULBACTAM; TETRACYCLINE; VANCOMYCIN;

ADULT; BLOOD CULTURE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; HUMAN; LETTER; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; PNEUMONIA; STAPHYLOCOCCUS INFECTION; THORAX RADIOGRAPHY; THROMBOCYTOPENIA;

EID: 31344437484     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid1201.050279     Document Type: Letter

References (10)

1. Vandenesch F, Naimi T, Enright MC, Lina G, Nimmo GR, Heffernan H, et al. Community-acquired methicillin-resistant Staphylococcus aureus carrying Panton-Valentine leukocidin genes: worldwide emergence. Emerg Infect Dis. 2003;9:978-84.
2. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing. Fifteenth informational supplement. NCCLS document M100-S15. Wayne (PA): The Committee; 2005.
3. Ip M, Lyon DJ, Chio F, Enright MC, Cheng AF. Characterization of isolates of methicillin-resistant Staphylococcus aureus from Hong Kong by phage typing, pulsed-field gel electrophoresis, and fluorescent amplified-fragment length polymorphism analysis. J Clin Microbiol. 2003;41:4980-5.
4. Chambers HF. Methicillin resistance in staphylococci: molecular and biochemical basis and clinical implications. Clin Microbiol Rev. 1997;10:781-91.
5. Brown DF. Detection of methicillin/oxacillin resistance in staphylococci. J Antimicrob Chemother. 2001;48(Suppl 1):65-70.
6. Varaldo PE. The "borderline methicillin-susceptible" Staphylococcus aureus. J Antimicrob Chemother. 1993;31:1-4.
7. Naimi TS, LeDell KH, Como-Sabetti K, Borchardt SM, Boxrud DJ, Etienne J, et al. Comparison of community- and health care-associated methicillin-resistant Staphylococcus aureus infection. JAMA. 2003;290:2976-84.
8. Francis JS, Doherty MC, Lopatin U, Johnson CP, Sinha G, Ross T, et al. Severe community-onset pneumonia in healthy adults caused by methicillin-resistant Staphylococcus aureus carrying the Panton-Valentine leukocidin gene. Clin Infect Dis. 2005;40:100-7.
9. Hirano L, Bayer AS. Beta-lactam-beta-lactamase-inhibitor combinations are active in experimental endocarditis caused by betalactamase-producing oxacillin-resistant staphylococci. Antimicrob Agents Chemother. 1991;35:685-90.
10. Balslev U, Bremmelgaard A, Svejgaard E, Havstreym J, Westh H. An outbreak of borderline oxacillin-resistant Staphylo-coccus aureus (BORSA) in a dermatological unit. Microb Drug Resist. 2005;11:78-81.